Study of TDM-180935 in Atopic Dermatitis Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel J. Piacquadio, M.D.
Therapeutics Incorporated
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Site 5
Rolling Meadows, Illinois, United States
- Site 8
Covington, Louisiana, United States
- Site 4
New Brighton, Minnesota, United States
- Site 7
Anderson, South Carolina, United States
- Site 3
Austin, Texas, United States
- Site 1
College Station, Texas, United States
- Site 2
Norfolk, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Apr 2024
- Primary completion
- 8 Mar 2025
- Completion
- 8 Apr 2025
- Last update posted
- 24 Apr 2025
- Registered enrollment
- 24
- Registry id
- NCT06363461
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.